These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29153510)

  • 21. Long-Term Prognostic Implications of Cerebral Microbleeds in Chinese Patients With Ischemic Stroke.
    Lau KK; Wong YK; Teo KC; Chang RSK; Tse MY; Hoi CP; Chan CY; Chan OL; Cheung RHK; Wong EKM; Kwan JSK; Hui ES; Mak HKF
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Risk of Intracranial Hemorrhage in Japanese Patients with Acute Large Vessel Occlusion; subanalysis of the RESCUE-Japan registry.
    Enomoto Y; Yoshimura S; Egashira Y; Yamagami H; Sakai N;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1076-1080. PubMed ID: 26923092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapies are associated with hematoma enlargement and increased mortality in intracranial hemorrhage.
    de Gea-García JH; Fernández-Vivas M; Núñez-Ruiz R; Rubio-Alonso M; Villegas I; Martínez-Fresneda M
    Med Intensiva; 2012 Nov; 36(8):548-55. PubMed ID: 22386331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet Therapy, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Meta-Analysis.
    Qiu J; Ye H; Wang J; Yan J; Wang J; Wang Y
    Stroke; 2018 Jul; 49(7):1751-1754. PubMed ID: 29798835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anticoagulant and antiplatelet drugs on the risk for hospital admission for traumatic injuries: a case-control and population-based study.
    Di Bartolomeo S; Marino M; Valent F; De Palma R
    J Trauma Acute Care Surg; 2014 Feb; 76(2):437-42. PubMed ID: 24398774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; DeRosa PA; Landes E; Lei S; Khandji J; Gutbrod S; Connolly ES
    Neurol Res; 2010 Sep; 32(7):706-10. PubMed ID: 20819399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative antiplatelet therapy may be a risk factor for postoperative ischemic complications in intracranial hemorrhage patients.
    Yang J; Wang K; Han C; Liu Q; Zhang S; Wu J; Jiang P; Yang S; Guo R; Mo S; Yang Y; Zhang J; Liu Y; Cao Y; Wang S
    Int J Neurosci; 2024 Aug; 134(8):899-905. PubMed ID: 36503400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter retrospective study evaluating the impact of desmopressin on hematoma expansion in patients with antiplatelet-associated intracranial hemorrhage.
    Summers A; Singh J; Lai M; Schomer KJ; Martin R; Vitt JR; Derry KL; Box K; Chu F; Arias V; Minokadeh A; Stern-Nezer S; Groysman L; Lee BJ; Atallah S
    Thromb Res; 2023 Feb; 222():96-101. PubMed ID: 36610266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of short-term dual- versus mono-antiplatelet therapy in patients with ischemic stroke or TIA: a meta-analysis of 10 randomized controlled trials.
    Liu Y; Fei Z; Wang W; Fang J; Zou M; Cheng G
    J Neurol; 2016 Nov; 263(11):2247-2259. PubMed ID: 27541045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors.
    Ma S; Patell R; Miller E; Ren S; Marquez-Garcia J; Panoff S; Sharma R; Pinson A; Elavalakanar P; Weber G; Uhlmann E; Neuberg D; Soman S; Zwicker JI
    J Thromb Haemost; 2023 May; 21(5):1148-1155. PubMed ID: 36740041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reported antiplatelet use influences long-term outcome independently in deep intracerebral hemorrhage.
    Kuramatsu JB; Mauer C; Kiphuth IC; Lücking H; Kloska SP; Köhrmann M; Huttner HB
    Neurosurgery; 2012 Feb; 70(2):342-50; discussion 350. PubMed ID: 21826030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
    Kumar G; Goyal MK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
    Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the Presence of Subdural Hemorrhage Increase the Risk of Intracranial Hemorrhage Expansion after the Initiation of Antithrombotic Medication?
    Pandya U; Pattison J; Karas C; O'Mara M
    Am Surg; 2018 Mar; 84(3):416-421. PubMed ID: 29559058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet Therapy after Intracerebral Hemorrhage and Subsequent Clinical Events: A 12-Year South Korean Cohort Study.
    Moon JY; Lee JG; Kim JH
    Eur Neurol; 2021; 84(3):183-191. PubMed ID: 33831859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage.
    Yildiz OK; Arsava EM; Akpinar E; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):760-6. PubMed ID: 21683617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
    Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.